These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Effect of 4-aminopyridine on upbeat and downbeat nystagmus elucidates the mechanism of downbeat nystagmus. Glasauer S, Strupp M, Kalla R, Büttner U, Brandt T. Ann N Y Acad Sci; 2005 Apr; 1039():528-31. PubMed ID: 15827015 [Abstract] [Full Text] [Related]
27. The therapeutic mode of action of 4-aminopyridine in cerebellar ataxia. Alviña K, Khodakhah K. J Neurosci; 2010 May 26; 30(21):7258-68. PubMed ID: 20505092 [Abstract] [Full Text] [Related]
30. Aminopyridines for the treatment of neurologic disorders. Strupp M, Teufel J, Zwergal A, Schniepp R, Khodakhah K, Feil K. Neurol Clin Pract; 2017 Feb 26; 7(1):65-76. PubMed ID: 28243504 [Abstract] [Full Text] [Related]
31. Potassium channels, the cerebellum, and treatment for downbeat nystagmus. Leigh RJ. Neurology; 2003 Jul 22; 61(2):158-9. PubMed ID: 12874391 [No Abstract] [Full Text] [Related]
33. Potassium channel blocker 4-aminopyridine is effective in interictal cerebellar symptoms in episodic ataxia type 2--a video case report. Löhle M, Schrempf W, Wolz M, Reichmann H, Storch A. Mov Disord; 2008 Jul 15; 23(9):1314-6. PubMed ID: 18442126 [Abstract] [Full Text] [Related]
34. Episodic ataxia type 2. Strupp M, Zwergal A, Brandt T. Neurotherapeutics; 2007 Apr 15; 4(2):267-73. PubMed ID: 17395137 [Abstract] [Full Text] [Related]